Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Genomma Lab Internacional, S.A.B. de C.V.
Genomma Lab makes and sells over-the-counter medicines, generic drugs, and personal care products, mostly in Mexico and Latin America.
Genomma Lab is a Mexican company that sells the everyday health and beauty products people grab at the pharmacy or supermarket — pain relievers, stomach remedies, acne treatments, shampoos, and deodorants. It doesn't discover new medicines. It looks at products that already sell well, often ones that are popular in the United States or Europe, and creates its own version for Latin America, then pushes it hard through TV, radio, and in-store displays.
Its main edge is marketing, not chemistry. Genomma buys or licenses brands, builds them into household names, and floods the airwaves with ads. You have probably seen its products even if the name Genomma means nothing to you: brand names like Tafirol for pain, Next for acne, or Medicasp for dandruff are the ones on the shelf, while Genomma stays in the background as the company that owns them. Most of its money comes from Mexico, but it has expanded across Latin America and into the United States, where it sells to the large Hispanic market. It also runs a smaller generic-drugs business, selling lower-cost copies of medicines whose patents have expired. That side is growing as governments and insurers push for cheaper alternatives.
The business has had a bumpy ride. Genomma grew fast for years on aggressive advertising and acquisitions, then hit trouble when Mexico's government cut back on buying medicines and a major contract dispute hurt its results. It has also carried a heavy debt load, which it has worked to pay down. The core idea remains simple: own the brands people recognize, keep them cheap enough for everyday shoppers, and sell them in as many stores as possible.
Saved answer · last researched 12 Nov 2026